Меню
Идёт набор NCT06768216

Effect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescent With MASLD

Без фазы С лечением Metabolic Dysfunction-Associated Steatotic Liver Disease

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Indianized version of Mediterranean Diet, Low Fat Diet, Physical Activity.
Кому может быть актуально
Состояния в реестре: Metabolic Dysfunction-Associated Steatotic Liver Disease. Базовые параметры: 8 лет — 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Индия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Effect of Indianized Version of Mediterranean Diet vs. Low Fat Diet on Hepatic Steatosis in Overweight Children and Adolescent With MASLD: A Randomized Control Trial

Обзор

NAFLD encompasses the entire spectrum of Fatty liver disease in individuals without significant alcohol consumption, ranging from fatty liver to steatohepatitis to cirrhosis. A high prevalence of NAFLD (62.5%) was observed in overweight/obese Indian adolescent (1). Lifestyle modification consisting of diet, exercise and weight loss has been advocated to treat patients with NAFLD (2). EASL guidelines recommends that the macronutrient in the diet should be adjusted according to the Mediterranean diet for weight loss (3). Mediterranean diet helps to decrease hepatic fat by decreasing lipogenesis, fibrogenesis, inflammation, oxidative stress and by increasing fatty acids beta oxidation (4). There are various studies showing benefits of using other diets such as Low Fat Diet, Low Carbdohydrate diet, Low Fructose Diet, et. Though there are numerous studies in adults comparing Mediterranean diet vs Low Fat diet, date regarding the same in children are lacking. The aim of this study will be to compare the Effect of Indianized version of Mediterranean diet vs. Low Fat Diet on Hepatic Steatosis in Overweight children and adolescent with MASLD.

Подробное описание

Aim: To Study the effect of Indianized version of Mediterranean diet versus Low Fat diet on Non-Invasive markers of hepatic steatosis in children and adolescent with MASLD.

Primary objective: To compare the proportions of patients achieving normal CAP values (\<236db/m) after 180 days of IMD versus LFD in children and adolescent with MASLD.

Secondary objectives:

* To compare the changes in CAP values after 180 days of IMD versus LFD in children and adolescent with MASLD. * To compare the grades of Fatty liver on Ultrasonography after 180 days between the two study groups. * To compare the changes in CAP value in PNPLA3 mutant children. * To study the change in Adiponectin, Cytokines(TNF alpha, IL 6, IL-1β, and IL-17) after 180 days between the two study groups. * To compare the changes in following parameters in both study groups: Weight, BMI, HOMA IR and Lipid profile. * To compare the adherence to IMD, with the help of Modified KIDMED score. * Study design: Prospective, Randomized, Single center Open label study. * Children and adolescent aged 8 to 18 years with CAP \> 236dB/m will be enrolled in the study. Consent for dietary intervention will be taken. Baseline parameters analysed includes:

* Anthropometry :

\- Weight, Height, BMI, Waist circumference * Imaging:

\- Ultrasonography abdomen, Fibroscan (LSM, CAP values) * Biochemical parameters:

\- ALT, AST, Lipid profile, HOMA IR * Adiponectin \& Cytokines: TNF alpha, IL6, IL-1β, and IL-17 * Liver Biopsy when indicated: ALT\>80, LSM\>8.6. * Intervention:

Both the groups will have be given a handmade individualised (according to weight) specific diet to follow. Indo-Mediterranean diet will be given to one group and other group will have Calorie restricted diet. Indo Mediterranean diet will have Carbohydrates 40-45%, fats 30-35% and proteins 15-20%. Low fat diet will have 50-60% carbohydrate, 20-30% fat (with \<10% saturated fat), and 20% protein. Calories will be calculated according to the age specified RDA from ICMR guidelines. In Indo-Mediterranean diet, it will be specified to use Mustard oil, use of specific fruits like orange, apple, mosambi (avoid high glycemic fruits), use more of green leafy vegetables, Use of multigrain atta (Home made- 10 kg of multigrain atta will have - 8 kg of wheat + 500g each of Ragi+Bajra+ Jowar + Chana dal flour). They will be advised to eat Dairy products in moderation and if non vegetarian diet (Fish, chicken, only twice a week). Dry fruits (Walnuts) and herbs (cinnamon, garlic, basil, and pepper) will be an important part of the diet. In the Low Fat Diet group, there will be only be restriction of total fat content to less than \<30%. They can use whichever household oil, consume any fruit or vegetables, any atta and no restriction on diary or non-vegetarian diet. Along with this, both groups will be given a list of do's and dont's. In the list of Do's , it will be mentioned to Eat plenty of vegetables, Fruits, Nuts, Whole grains, at least 45- 60 mins of exercise (peer group activity - cycling, football, brisk walking), Screen time of less \<2 hrs /day (According to American academy of pediatrics) and Average hours of sleep in a day for age 8-18 = 8-9 hrs (According to American academy of sleep medicine). In the dont's list, it will be mentioned to avoid Sugar, Soda, Beverages, cold drinks, processed juices, processed food, junk foods, Maida, Ice cream, Creamy Desserts, Biscuit, chips and cake.

• Monitoring and assessment: All Parameters will be re-assessed at 180 days (except liver biopsy). Both groups will be explained to maintain a food diary mentioning cheat days (Food other than the diet given), screen time (\<2hrs/day), Exercise (45-60 mins/day, parameters will be checked by pedometer app) and average hours of sleep (8-9hrs/day). Food diary will be checked once in two weeks on phone calls or virtual OPD. Once weekly phone calls (30 mins) will be checked to see the adherence and to motivate the child. They will be required to follow up in OPD once in a month. Adherence to Indo Mediterranean diet will be assessed by Modified KIDMED score.

Вмешательства

  • Другое Indianized version of Mediterranean Diet
    Indo Mediterranean diet will have Carbohydrates 40-45%, fats 30-35% and proteins 15-20%. Mediterranean diet, it will be specified to use Mustard oil, use of specific fruits like orange, apple, mosambi (avoid high glycemic fruits), use more of green leafy vegetables, Use of multigrain atta (Home made- 10 kg of multigrain atta will have - 8 kg of wheat + 500g each of Ragi+Bajra+ Jowar + Chana dal flour).
  • Другое Low Fat Diet
    Low fat diet will have 50-60% carbohydrate, 20-30% fat (with \<10% saturated fat), and 20% protein. In the Low Fat Diet group, there will be only be restriction of total fat content to less than \<30%. They can use whichever household oil, consume any fruit or vegetables, any atta and no restriction on diary or non-vegetarian diet. Along with this, both groups will be given a list of do's and dont's. In the list of Do's , it will be mentioned to Eat plenty of vegetables, Fruits, Nuts, Whole grai
  • Другое Physical Activity
    At least 45- 60 mins of exercise (peer group activity - cycling, football, brisk walking),

Первичные конечные точки

  • To compare the proportions of patients achieving normal CAP values (<236db/m) after 180 days of IMD versus LFD in children and adolescent with MASLD. [Срок оценки: 180 days]
Вторичные конечные точки (9)
  • To compare the changes in CAP values after 180 days of IMD versus LFD in children and adolescent with MASLD. [Срок оценки: 180 days]
  • To compare the grades of Fatty liver on Ultrasonography after 180 days between the two study groups. [Срок оценки: 180 days]
  • To compare the changes in CAP value in PNPLA3 mutant children. [Срок оценки: 180 days]
  • To study the change in Adiponectin, Cytokines(TNF alpha, IL 6, IL-1β, and IL-17) after 180 days between the two study groups. [Срок оценки: 180 days]
  • To compare the changes in following parameters in both study groups: Weight. [Срок оценки: 180 days]
  • To compare the changes in following parameters in both study groups: BMI. [Срок оценки: 180 days]
  • To compare the changes in following parameters in both study groups: HOMA IR . [Срок оценки: 180 days]
  • To compare the changes in following parameters in both study groups: Lipid profile. [Срок оценки: 180 days]
  • To compare the adherence to IMD, with the help of Modified KIDMED score. [Срок оценки: 180 days]

Критерии участия

Критерии включения

  • Age: 8-18 years
  • BMI > 85th centile
  • CAP > 236

Критерии исключения

\- Other Liver diseases such as Viral hepatitis (Hep B and C), Autoimmune hepatitis, Wilson disease.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

Индия · 1 центр
  • Institute of Liver & Biliary Sciences — New Delhi

Идентификаторы

NCT: NCT06768216 · ILBS-MASDL-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗